Shilpa Medicare Limited — Important, 13-11-2024: Financial Result Updates

Shilpa Medicare Limited reported its consolidated financial results for the quarter and half-year ended September 30, 2024. Total revenue increased by 9% YoY to ₹34,879 lakh, driven by higher sales in pharmaceuticals and licensing fees. The net profit rose significantly to ₹1,794 lakh, with Earnings Per Share (EPS) at ₹1.83, reflecting operational efficiencies despite rising costs. Operational expenses registered a 17% increase, mainly driven by higher material costs and employee benefits.

The balance sheet shows total assets increasing to ₹3,11,732 lakh with total equity of ₹2,31,919 lakh, indicating a solid financial position. The company's strategic focus appears to be on maintaining cost control while pursuing growth opportunities in its core sector. Based on this performance and outlook, a hold rating is suggested, positioned amid operational challenges and market conditions.